TVARDI THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $19.5M | $247.1M | $13.5M |
| FY2022 | $23.5M | $182.2M | $63.7M |
| FY2023 | $68.8M | $125.8M | $51.8M |
| FY2024 | $40.8M | $35.2M | $31.6M |
| FY2025 | $11.1M | $32.1M | $20.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $19.5M | $247.1M | $13.5M |
| FY2022 | $23.5M | $182.2M | $63.7M |
| FY2023 | $68.8M | $125.8M | $51.8M |
| FY2024 | $40.8M | $35.2M | $31.6M |
| FY2025 | $11.1M | $32.1M | $20.7M |